Crossmark Global Holdings’s DexCom DXCM Stock Holding History

Crossmark Global Holdings’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.55M	Buy	67,557 +49,458	+273%	+$3.3M	0.06%	278
2026 Q1	$1.14M	Sell	18,099 -200	-1%	-$13.9K	0.02%	574
2025 Q4	$1.21M	Buy	18,299 +437	+2%	+$28.3K	0.02%	549
2025 Q3	$1.2M	Sell	17,862 -1,911	-10%	-$151K	0.02%	573
2025 Q2	$1.73M	Buy	19,773 +1,136	+6%	+$89K	0.03%	466
2025 Q1	$1.27M	Sell	18,637 -91	-0.5%	-$7.43K	0.02%	536
2024 Q4	$1.46M	Sell	18,728 -50	-0.3%	-$3.7K	0.03%	473
2024 Q3	$1.26M	Buy	18,778 +182	+1%	+$14.9K	0.02%	532
2024 Q2	$2.11M	Buy	18,596 +172	+0.9%	+$21.7K	0.04%	390
2024 Q1	$2.56M	Sell	18,424 -541	-3%	-$68K	0.05%	361
2023 Q4	$2.35M	Sell	18,965 -1,461	-7%	-$149K	0.05%	356
2023 Q3	$1.74M	Sell	20,426 -221	-1%	-$24.9K	0.04%	425
2023 Q2	$2.73M	Buy	20,647 +151	+0.7%	+$18.3K	0.06%	333
2023 Q1	$2.38M	Sell	20,496 -743	-3%	-$83.2K	0.06%	353
2022 Q4	$2.4M	Buy	21,239 +189	+0.9%	+$20.8K	0.06%	347
2022 Q3	$1.7M	Sell	21,050 -370	-2%	-$31.3K	0.05%	406
2022 Q2	$1.6M	Buy	21,420 +64	+0.3%	+$5.84K	0.04%	437
2022 Q1	$2.73M	Buy	21,356 +320	+2%	+$35K	0.06%	319
2021 Q4	$2.82M	Sell	21,036 -16,680	-44%	-$2.4M	0.06%	310
2021 Q3	$5.16M	Sell	37,716 -3,080	-8%	-$388K	0.12%	186
2021 Q2	$4.36M	Sell	40,796 -2,676	-6%	-$257K	0.1%	215
2021 Q1	$3.91M	Sell	43,472 -4,640	-10%	-$436K	0.1%	224
2020 Q4	$4.45M	Buy	48,112 +12,680	+36%	+$1.13M	0.11%	198
2020 Q3	$3.65M	Buy	35,432 +820	+2%	+$85.7K	0.1%	215
2020 Q2	$3.51M	Buy	+34,612	New	+$3.1M	0.1%	223
2018 Q4	–	Sell	-7,396	Closed	-$264K	–	1436
2018 Q3	$264K	Buy	+7,396	New	+$229K	0.01%	1398

Other funds holding DXCM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Crossmark Global Holdings's DXCM Position: Q2 2026 in Review

Crossmark Global Holdings increased its DexCom (DXCM) stake by 273% in Q2 2026, buying an estimated $3.3M and bringing the position to 67,557 shares worth $4.55M. The position accounts for 0.06% of the portfolio, ranked #278.

Crossmark Global Holdings first reported a position in DXCM in Q3 2018 and has held it in 26 quarters since. The position peaked at $5.16M in Q3 2021. 115 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Crossmark Global Holdings held 67,557 shares of DexCom worth $4.55M as of Q2 2026.
Crossmark Global Holdings bought 49,458 DexCom shares in Q2 2026, an estimated $3.3M.
DexCom made up 0.06% of Crossmark Global Holdings's portfolio in Q2 2026, its #278 holding.
Crossmark Global Holdings first reported a position in DexCom in Q3 2018 and has held it in 26 quarters since.
Crossmark Global Holdings's DexCom position peaked at $5.16M in Q3 2021.
115 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.